SCHEMBL9770338

SCHEMBL9770338

CC(F)(F)Oc1ccccc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA4 P22748 1/20 0.43
TSHR P16473 2/20 0.41
LTA4H P09960 2/20 0.41
MAPK1 P28482 1/20 0.39
ALDH1A1 P00352 2/20 0.38
PPARG P37231 2/20 0.37
PPARA Q07869 1/20 0.37
RIPK1 Q13546 1/20 0.36
PDK1 Q15118 1/20 0.36
PDK2 Q15119 1/20 0.36
PDK3 Q15120 1/20 0.36
PDK4 Q16654 1/20 0.36
GRIN2B Q13224 1/20 0.36
ALOX15 P16050 1/20 0.36
SLC6A2 P23975 1/20 0.36
TAAR1 Q96RJ0 1/20 0.36
KCNA3 P22001 1/20 0.35
ATM Q13315 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
CCR6 P51684 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8370351 0.86 KIF11 (0.46) ALDH1A1PPARGPPARA
SCHEMBL10477060 0.84 CA4 (0.43) CA4TSHRLTA4HMAPK1ALDH1A1
SCHEMBL13039942 0.80 CA4 (0.40) CA4TSHRLTA4HMAPK1ALDH1A1
SCHEMBL821312 0.80 CA4 (0.40) CA4TSHRLTA4HMAPK1ALDH1A1
SCHEMBL20003172 0.80 CA4 (0.40) CA4TSHRLTA4HMAPK1ALDH1A1
SCHEMBL17107524 0.80 LMNA (0.58) PPARGPPARASLC6A2L3MBTL1
SCHEMBL15372299 0.79 MAPT (0.47) TSHRALDH1A1SLC6A2L3MBTL1KCNH2
SCHEMBL4224012 0.78 CA4 (0.48) CA4TSHRLTA4HMAPK1ALDH1A1
SCHEMBL168125 0.78 KIF11 (0.47) TSHRLTA4HGRIN2BSLC6A2CCR6
SCHEMBL93074 0.78 CA4 (0.48) CA4TSHRLTA4HMAPK1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230271953-A1 Novel compounds for treatment of diseases related to DUX4 expression Facio Intellectual Property B.V. (NL) 2023-08-31 US disclosed
EP-3442961-B1 AGRICULTURAL CHEMICALS REDAG CROP PROT LTD (GB) 2021-03-24 EP disclosed
WO-2018102358-A1 METHODS OF TREATING OR PREVENTING COGNITIVE IMPAIRMENT USING INDANE ACETIC ACID DERIVATIVES BASED ON APOE4 GENOTYPE T3D THERAPEUTICS, INC. (US) 2018-06-07 WO disclosed
WO-2017178819-A1 AGRICULTURAL CHEMICALS REDAG CROP PROTECTION LTD (GB) 2017-10-19 WO disclosed
CN-104379574-B For suppressing the heterocyclic carbamate derivatives of the activity of ABL1, ABL2 and BCR ABL1 诺华股份有限公司 2017-03-01 CN disclosed
US-20160031890-A1 NOVEL METHODS, COMPOUNDS, AND COMPOSITIONS FOR INHIBITION OF ROS GRUENEBERG, Dorre A. 2016-02-04 US disclosed
EP-2604612-A1 C-ARYL GLUCOSIDE DERIVATIVES, PREPARATION RPOCESS AND PHARMACEUTICAL USE THEREOF Shanghai Hengrui Pharmaceutical Co. Ltd. (CN) 2013-06-19 EP disclosed
US-8268531-B2 Photoacid generator compounds and compositions CORNELL RESEARCH FOUNDATION, INC. (US) 2012-09-18 US disclosed
US-20110008732-A1 PHOTOACID GENERATOR COMPOUNDS AND COMPOSITIONS CORNELL RESEARCH FOUNDATION, INC. (US) 2011-01-13 US disclosed
US-7824839-B2 cationic lactone containing perfluorinated sulfonate or sulfonimides with iodonium or sulfonium anions as photoacid generator, a polyhydroxystyrene homo or copolymer and a solvent (propylene glycol/1,2-/, monoalkyl ether, ethyl lactone ); semiconductor, heat exposure, pattern forming; development CORNELL RESEARCH FOUNDATION, INC. (US) 2010-11-02 US disclosed
US-20090136868-A1 PHOTOACID GENERATOR COMPOUNDS AND COMPOSITIONS CORNELL RESEARCH FOUNDATION, INC. 2009-05-28 US disclosed
US-4981836-A Recording material FUJI PHOTO FILM CO., LTD. (JP) 1991-01-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230271953-A1 Novel compounds for treatment of diseases related to DUX4 expression UTRN, ZFX, CBX6 CA4 3935/4885TSHR 3539/4885LTA4H 3497/4885
US-20090136868-A1 PHOTOACID GENERATOR COMPOUNDS AND COMPOSITIONS ASIC1, PPA1, PPOX CA4 562/4885TSHR 3707/4885LTA4H 2278/4885
US-20160031890-A1 NOVEL METHODS, COMPOUNDS, AND COMPOSITIONS FOR INHIBITION OF ROS ROS1, NOX4, NOX1 CA4 1518/4885TSHR 4141/4885LTA4H 3556/4885
US-20110008732-A1 PHOTOACID GENERATOR COMPOUNDS AND COMPOSITIONS ASIC1, PPA1, PPOX CA4 562/4885TSHR 3707/4885LTA4H 2278/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.